Pembrolizumab in the Neoadjuvant Setting Benefits EFS in High-Risk Melanoma
Neoadjuvant IO Boosts High-Risk Melanoma EFS Results from the phase 2 SWOG S1801 study show that for patients given pembrolizumab…
Blog - Melanoma360
09/11/2022
Pembrolizumab in the Neoadjuvant Setting Benefits EFS in High-Risk Melanoma
Neoadjuvant IO Boosts High-Risk Melanoma EFS Results from the phase 2 SWOG S1801 study show that for patients given pembrolizumab…
|
09/06/2022
Survivor Spotlight: Erich & Jenn Djordjevic
By Mara Klecker Note: Erich passed away on September 28th, 2022, the same week his story ran in our newsletter.…
|
09/06/2022
Survivor Spotlight: Bev Johnson, Mucosal Melanoma Survivor
By Mara Klecker Bev Johnson figured the abnormal bleeding she was experiencing was a side effect of her IUD losing…
|
08/09/2022
The Trouble with Toxic Positivity With Whitney Goodman, LMFT, Author
When going through difficulty, many people turn to friends and family for support. But what happens when those people dismiss…
|
07/22/2022
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody Combination Opdualag
(reprint from Business Wire, published: July 22, 2022) Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody…
|
07/13/2022
2022: The State of Sunscreen in the U.S.
July is UV Safety Awareness Month, and with so much time spent outdoors, practicing sun safety should be top of…
07/13/2022
Sun Safety and Psychological Challenges For Melanoma Survivors
Many skin cancer survivors develop high anxiety regarding sun exposure and being outside, especially during summer. How can active coping…
|
07/12/2022
Parenting While Living With Melanoma
by Mara Klecker It’s natural and common to worry about how a parent’s cancer diagnosis and treatment is going to…
|
|
06/22/2022
Survivorship: Living Well with Melanoma
Cancer Survivorship begins the moment you learn of your diagnosis and continues long after treatment. And thanks to medical advances,…
|
06/22/2022
Steve Banks, Stage III Survivor, Doesn’t Let Melanoma Define His Life
by Mara Klecker Steve Banks doesn’t often bring up his melanoma diagnosis during a first date, though he’s always forthright…
|
Recent Posts
Nov. 22, 2024
Replimune Receives Breakthrough Therapy Designation for RP1 and Submits BLA to FDA
Nov. 22, 2024
Meaning-Centered Psychotherapy for Cancer Patients
Nov. 05, 2024
Crafting Hope: Chris Krizek’s Journey from Cancer Patient to AIM Fundraiser with Wine Cork Creations
Nov. 04, 2024
Book Suggestions for Caregivers
Oct. 28, 2024